Daniel Truong

5.6k total citations
136 papers, 3.9k citations indexed

About

Daniel Truong is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Daniel Truong has authored 136 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Neurology, 59 papers in Cellular and Molecular Neuroscience and 22 papers in Physiology. Recurrent topics in Daniel Truong's work include Neurological disorders and treatments (79 papers), Botulinum Toxin and Related Neurological Disorders (58 papers) and Parkinson's Disease Mechanisms and Treatments (39 papers). Daniel Truong is often cited by papers focused on Neurological disorders and treatments (79 papers), Botulinum Toxin and Related Neurological Disorders (58 papers) and Parkinson's Disease Mechanisms and Treatments (39 papers). Daniel Truong collaborates with scholars based in United States, Thailand and Germany. Daniel Truong's co-authors include Roongroj Bhidayasiri, Joseph Jankovic, Kwok‐Keung Tai, Karen Frei, Rae R. Matsumoto, Robert A. Hauser, Cynthia Comella, Dirk Dressler, Wolfgang H. Jost and Brian R. de Costa and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Daniel Truong

134 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Truong United States 35 2.7k 1.4k 684 598 292 136 3.9k
Ruth Djaldetti Israel 36 3.0k 1.1× 1.2k 0.8× 598 0.9× 760 1.3× 384 1.3× 129 4.7k
Sadako Kuno Japan 33 1.8k 0.7× 1.5k 1.0× 354 0.5× 622 1.0× 260 0.9× 91 3.5k
Paolo Martinelli Italy 33 2.4k 0.9× 928 0.7× 342 0.5× 532 0.9× 369 1.3× 118 3.6k
Carlos Singer United States 32 2.8k 1.0× 1.1k 0.8× 400 0.6× 391 0.7× 409 1.4× 134 3.8k
Shigeki Kuzuhara Japan 35 2.1k 0.8× 823 0.6× 910 1.3× 867 1.4× 320 1.1× 190 3.8k
Petr Kaňovský Czechia 35 2.8k 1.0× 801 0.6× 458 0.7× 291 0.5× 484 1.7× 232 4.0k
Dirk Woitalla Germany 32 2.3k 0.9× 993 0.7× 556 0.8× 944 1.6× 258 0.9× 112 3.8k
Noriyuki Matsukawa Japan 30 1.1k 0.4× 1.0k 0.8× 635 0.9× 1.1k 1.9× 285 1.0× 177 3.8k
Masato Asahina Japan 27 1.5k 0.5× 745 0.5× 623 0.9× 429 0.7× 164 0.6× 109 2.7k
Jarosław Sławek Poland 32 2.3k 0.8× 809 0.6× 416 0.6× 379 0.6× 444 1.5× 229 3.1k

Countries citing papers authored by Daniel Truong

Since Specialization
Citations

This map shows the geographic impact of Daniel Truong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Truong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Truong more than expected).

Fields of papers citing papers by Daniel Truong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Truong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Truong. The network helps show where Daniel Truong may publish in the future.

Co-authorship network of co-authors of Daniel Truong

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Truong. A scholar is included among the top collaborators of Daniel Truong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Truong. Daniel Truong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Truong, Daniel, et al.. (2025). Characteristics of pain symptoms in Parkinson’s disease. Clinical Parkinsonism & Related Disorders. 13. 100404–100404.
2.
Truong, Daniel, et al.. (2024). Multiple system atrophy: Diagnostic challenges and a proposed diagnostic algorithm. Clinical Parkinsonism & Related Disorders. 11. 100271–100271. 3 indexed citations
3.
Truong, Daniel, et al.. (2023). Bone Health in Young Athletes: a Narrative Review of the Recent Literature. Current Osteoporosis Reports. 21(4). 447–458. 8 indexed citations
4.
Bhidayasiri, Roongroj, John M. Kane, Karen Frei, et al.. (2020). Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool. Parkinsonism & Related Disorders. 77. 141–145. 6 indexed citations
5.
Truong, Daniel & Karen Frei. (2018). Setting the record straight: The nosology of tardive syndromes. Parkinsonism & Related Disorders. 59. 146–150. 14 indexed citations
6.
Pahwa, Rajesh, Caroline M. Tanner, Robert A. Hauser, et al.. (2015). Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study). Movement Disorders. 30(6). 788–795. 113 indexed citations
7.
Simon, David K., Cai Wu, Barbara C. Tilley, et al.. (2015). Caffeine and Progression of Parkinson Disease. Clinical Neuropharmacology. 38(5). 163–169. 20 indexed citations
8.
Jinnah, Hyder A., et al.. (2014). Treatment of myoclonus-dystonia syndrome with tetrabenazine. Parkinsonism & Related Disorders. 20(12). 1423–1426. 25 indexed citations
9.
Hauser, Robert A., et al.. (2012). AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies. Journal of Neural Transmission. 120(2). 299–307. 19 indexed citations
10.
Truong, Daniel, Andrea Stenner, & G Reichel. (2009). Current Clinical Applications of Botulinum Toxin. Current Pharmaceutical Design. 15(31). 3671–3680. 39 indexed citations
11.
Simon, David K., Christopher J. Swearingen, Robert A. Hauser, et al.. (2008). Caffeine and Progression of Parkinson Disease. Clinical Neuropharmacology. 31(4). 189–196. 32 indexed citations
12.
Truong, Daniel. (2007). Botulinum toxin therapy. Elsevier eBooks. 155(1). 103–108. 1 indexed citations
13.
Tai, Kwok‐Keung & Daniel Truong. (2007). Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus. Journal of Neural Transmission. 114(12). 1547–1551. 37 indexed citations
14.
Bhidayasiri, Roongroj & Daniel Truong. (2007). Motor complications in Parkinson disease: Clinical manifestations and management. Journal of the Neurological Sciences. 266(1-2). 204–215. 45 indexed citations
15.
Bhidayasiri, Roongroj, Francisco Cardoso, & Daniel Truong. (2006). Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations. European Journal of Neurology. 13(s1). 21–29. 69 indexed citations
16.
Frei, Karen, Daniel Truong, & Dirk Dressler. (2006). Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations. European Journal of Neurology. 13(s1). 30–35. 36 indexed citations
17.
Kanthasamy, Anumantha G., et al.. (2000). Animal model of posthypoxic myoclonus: II. Neurochemical, pathologic, and pharmacologic characterization. Movement Disorders. 15(S1). 31–38. 18 indexed citations
18.
19.
Matsumoto, Rae R., et al.. (1995). Strychnine-insensitive glycine site antagonists attenuate a cardiac arrest-induced movement disorder. European Journal of Pharmacology. 275(2). 117–123. 16 indexed citations
20.
Matsumoto, Rae R., et al.. (1995). Association between brain indole levels and severity of posthypoxic myoclonus in rats. Pharmacology Biochemistry and Behavior. 50(4). 533–538. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth Djaldetti Breakdown of academic impact, for papers by Sadako Kuno Breakdown of academic impact, for papers by Paolo Martinelli Breakdown of academic impact, for papers by Carlos Singer Breakdown of academic impact, for papers by Shigeki Kuzuhara Breakdown of academic impact, for papers by Petr Kaňovský Breakdown of academic impact, for papers by Dirk Woitalla Breakdown of academic impact, for papers by Noriyuki Matsukawa Breakdown of academic impact, for papers by Masato Asahina Breakdown of academic impact, for papers by Jarosław Sławek
Rankless by CCL
2026